Home > Insider Trading > Filing (0000899243-21-043038)

Filing Details

Accession Number:: 0000899243-21-043038
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-04 17:41:25
Reporting Period:: 2021-11-02

Accepted Time:: 2021-11-04 17:41:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
730272	Repligen Corp	RGEN	Biological Products, (No Disgnostic Substances) (2836)	042729386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1261506	A Karen Dawes	C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-11-02	64	$299.02	93,583	No	4	S	Direct
Common Stock	Disposition	2021-11-02	251	$301.20	93,332	No	4	S	Direct
Common Stock	Disposition	2021-11-02	446	$301.97	92,886	No	4	S	Direct
Common Stock	Disposition	2021-11-02	532	$303.48	92,354	No	4	S	Direct
Common Stock	Disposition	2021-11-02	124	$304.23	92,230	No	4	S	Direct
Common Stock	Disposition	2021-11-02	700	$305.91	91,530	No	4	S	Direct
Common Stock	Disposition	2021-11-02	283	$306.49	91,247	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.
$301.20 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.70 to $301.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$301.97 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.71 to $302.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$303.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.89 to $303.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$304.23 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.01 to $304.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$305.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.24 to $306.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$306.49 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.40 to $307.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range